News & Views

We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.  

Read more
Show me:

All News and views

Research and new developments

Healthy living and emotional wellbeing

Policy and campaigning news

Getting involved

Back to Top
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk